Germline variant analysis from a cohort of patients with severe hypertriglyceridemia in Brazil

• Published in: Molecular genetics and metabolism reports Vol. 40; p. 101100
• Main Authors: Mendes, Camila, Loureiro, Thereza, Villela, Darine, Bittencourt, Marcelo Imbroinise, Sobreira, Joselito, Bermeo, Diana, Gomes, Mireille, Alencar, Dayse, de Castro, Luciana Santos Serrao, Fock, Rodrigo Ambrosio, Tinoco, Maria Luisa, Galvão, Henrique, Scapulatempo-Neto, Cristovam, Schiavetti, Katia, Senerchia, Andreza A., Gurgel, Maria Helane Costa
• Format: Journal Article
• Language: English
• Published: Elsevier Inc 01.09.2024; Elsevier
• Subjects: Brazilian population; Diagnostic yield; Dyslipidemia; Genetic testing; Germline variant analysis; Research Paper; Severe hypertriglyceridemia; Triglycerides; Brazilian population; Diagnostic yield; Germline variant analysis; Dyslipidemia; Triglycerides; Genetic testing; Severe hypertriglyceridemia
• ISSN: 2214-4269; 2214-4269
• DOI: 10.1016/j.ymgmr.2024.101100

Hypertriglyceridemia (HTG) is a common dyslipidemia associated with an increased risk of cardiovascular disease and pancreatitis. It is well stablished that the severe cases of disease often present with an underlying genetic cause. In this study, we determined the frequency and variation spectrum of genes involved in the triglyceride metabolism in a series of Brazilian patients with severe HTG. A total of 212 patients with very high HTG, defined with fasting triglycerides (TG) ≥ 880 mg/ dL, that underwent a multi-gene panel testing were included in this research. Germline deleterious variants (i.e. Pathogenic/Likely Pathogenic (P/LP) variants) were identified in 28 out of 212 patients, reflecting an overall diagnostic yield of 13% in our cohort. Variants of unknown significance (VUS) were identified in 87 patients, and represent 80% of detected variants in this dataset. We confirm the LPL as the most frequently mutated gene in patients with severe HTG, and we had only one suspected case of familial chylomicronemia syndrome, caused by a homozygous variant in LMF1, in our cohort. Notably, we report 16 distinct and novel variants (P/LP and VUS), each of them representing a single case, not previously reported in any public databases or other studies. Our data expand our knowledge of genetic variation spectrum in patients with severe HTG in the Brazilian population, often underrepresented in public genomic databases, being also a valuable clinical resource for genetic counseling and healthcare programs in the country.